Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

799 résultats trouvés

Studying the involvement of cell surface RNA binding proteins in ALS pathogenesis

Amyotrophic lateral sclerosis (known as ALS or Lou Gehrig’s disease) is a debilitating disease that causes loss of control over muscles and leads to death quickly after diagnosis.


Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2025

Insulin resistance in the mesolimbic system, a novel hypothesis for depression associated with metabolic resistance from obesity.

Depression and anxiety are highly prevalent in people with obesity and type 2 diabetes.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Santé mentale
Province
Alberta
DATE DE DÉBUT
2024

Apolipoprotein receptor 2 in AD-related brain vessel dysfunction

What is the role of apolipoprotein receptor 2, a protein found in the brain vessels, in Alzheimer’s disease ?


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Alberta
DATE DE DÉBUT
2024

Understanding brain development and maintenance via spatial transcriptomics

We identified changes in the gene called IRF2BPL (Interferon Regulatory Factor 2 Binding Protein Like) as the cause of a severe brain disorder in children called NEDAMSS (Neurodevelopmental disorder with abnormal movements, loss of speech and seizures).


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Développement neurologique
Concours
Les futurs leaders de la recherche sur le cerveau au Canada
Province
Manitoba
DATE DE DÉBUT
2024

Dynamic palmitoylation regulates TDP-43 nucleocytoplasmic transport in ALS

Common features in amyotrophic lateral sclerosis (ALS) include misdirected proteins that build up over time and lead to large protein clumps that are toxic to the cell and lead to cell death.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2024

Brain-heart dynamics in treatment-resistant depression and the effects of repetitive transcranial magnetic stimulation

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neurostimulation therapy, recommended by Canadian guidelines as a first-line intervention for major depression that does not respond to an adequate course of pharmacological therapy, known as treatment-resistant depression (TRD).


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Santé mentale
Concours
Prix Rising Stars pour les stagiaires
Province
Colombie-Britannique
DATE DE DÉBUT
2024

A combined in-vivo ex-vivo approach to investigate imaging biomarkers in ALS diagnosis and aetiology

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor function and ultimately death.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Concours
Prix Rising Stars pour les stagiaires
Province
Québec
DATE DE DÉBUT
2024

The application of 3D models to assess the role of microglia in neurodegenerative disorders

Challenge: Alzheimer’s disease (AD) is characterized by a decline in cognitive function, yet it is now widely acknowledged that as the disease advances, dopaminergic neurons in the midbrain become particularly vulnerable, leading to non-cognitive symptoms such as motor dysfunction.


TYPE DE SUBVENTION
Subventions de la plate-forme
Domaine de recherche
Neurodégénérescence
Concours
CQDM - Brain Canada - Quantum Leap
Province
Québec
DATE DE DÉBUT
2024

Targeting KCC2 for rescuing functional impairments in Alzheimer’s disease

Within the brain, cells communicate by sending signals that either enhance or dampen the activity of other cells.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2024

Impact of 2-hydroxyglutarate-induced astrocytes reactivity in low-grade glioma progression and recurrence

Mutations in the metabolic enzymes are commonly observed in brain cancers.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Le cancer
Concours
Subventions de fonctionnement du CRS
Province
Québec
DATE DE DÉBUT
2024